Status:
COMPLETED
Efficacy of a Web-based Tailored Self-management Program
Lead Sponsor:
National Cancer Center, Korea
Collaborating Sponsors:
Seoul National University
Asan Medical Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
20+ years
Phase:
NA
Brief Summary
Life style interventions that promote exercise and a healthy diet, which have the potential to improve health-related quality of life (HRQOL), may be particularly appropriate for cancer survivors. The...
Detailed Description
The purpose of the study was to develop a web-based, stage-matched Exercise and Diet Planning program and to examine effects of the program on implementation of exercise and diet, self-efficacy, HRQOL...
Eligibility Criteria
Inclusion
- Women aged 20 years and older
- Histologically confirmed stage 0 to III breast cancer who received curative breast cancer surgery within 12 months since completion of primary cancer treatment and 2 years since diagnosis
- Serum platelet ≥ 100,000/mm3
- Serum hemoglobin ≥ 10g/dl
- Not met one or more behavior goals: i) energy expenditure of aerobic exercise ≥ 12.5 kcal/kg/week; ii) intake of vegetables except kimchi ≥ 5 serv/day and intake of fruit 1-2 serv/day; iii) maintenance of healthy weight (18.5 kg/m2 ≤ BMI \< 23 kg/m2)
- Ability to use internet, and being accessible internet at home
- Mobile phone user
- Consent form to participate in the study
Exclusion
- Currently receiving any cancer treatment
- Conditions that could limit adherence to an unsupervised exercise program such as uncontrolled congestive heart failure or angina, recent myocardial infarction, or breathing difficulties requiring oxygen use or hospitalization; walker or wheelchair use; or plans to have hip or knee replacement
- Conditions that could interfere with a high vegetable and fruit diet, such as kidney failure or chronic warfarin use
- Progressive malignant disease or additional primary cancers
- Infectious condition (body temperature ≥ 37.2℃ or WBC ≥ 11,000mm3)
- Inability to use computer or internet
- Visual and motor dysfunction
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT01512069
Start Date
October 1 2011
End Date
August 1 2012
Last Update
April 24 2014
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Center
Gyenggi-do, Goyang-si, South Korea, 410-769
2
Asan Medical Center
Seoul, South Korea
3
Korea University Anam Hospital
Seoul, South Korea
4
Seoul National University
Seoul, South Korea